Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Storkus

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Cytometry|March 1, 1986
Quantitation and sorting of vitally stained natural killer cell-target cell conjugates by dual beam flow cytometryW J Storkus, A E Balber, J R Dawson
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1994
Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytesT Itoh, W J Storkus, E Gorelik, et al.
Cancer Gene Therapy|July 16, 2011
Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32Y Qu, J L Taylor, A Bose, et al.
Cellular Immunology|January 10, 1996
Class I-like CD1A-C do not protect target cells from NK-mediated cytolysisW J Storkus, M Wei, P Cresswell, et al.
Methods in Molecular Medicine|March 5, 2011
The immunology of DNA vaccinesT Tüting, J Austyn, W J Storkus, et al.
European Journal of Immunology|November 22, 1997
Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivoT Tüting, A B DeLeo, M T Lotze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1992
Peptide-induced modulation of target cell sensitivity to natural killingW J Storkus, R D Salter, P Cresswell, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancerH J Zeh, S Hurd, W J Storkus, et al.
Infection and Immunity|March 1, 1990
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibodyM F Miller, T G Mitchell, W J Storkus, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elutionW J Storkus, H J Zeh, R D Salter, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Cytometry|March 1, 1986
Quantitation and sorting of vitally stained natural killer cell-target cell conjugates by dual beam flow cytometryW J Storkus, A E Balber, J R Dawson
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1994
Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytesT Itoh, W J Storkus, E Gorelik, et al.
Cancer Gene Therapy|July 16, 2011
Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32Y Qu, J L Taylor, A Bose, et al.
Cellular Immunology|January 10, 1996
Class I-like CD1A-C do not protect target cells from NK-mediated cytolysisW J Storkus, M Wei, P Cresswell, et al.
Methods in Molecular Medicine|March 5, 2011
The immunology of DNA vaccinesT Tüting, J Austyn, W J Storkus, et al.
European Journal of Immunology|November 22, 1997
Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivoT Tüting, A B DeLeo, M T Lotze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1992
Peptide-induced modulation of target cell sensitivity to natural killingW J Storkus, R D Salter, P Cresswell, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancerH J Zeh, S Hurd, W J Storkus, et al.
Infection and Immunity|March 1, 1990
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibodyM F Miller, T G Mitchell, W J Storkus, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elutionW J Storkus, H J Zeh, R D Salter, et al.
Pageof 8